Related Experiment Video
Updated: Mar 27, 2026

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
Published on: September 28, 2018
A scale-down mini-bioreactor for the acceleration of data-driven bioprocess optimisation in cell therapy
Giuseppe Adriano Adriano Asaro1,2, Ioannis Papantoniou2,3, Jean-Marie Aerts1,2
1M3-BIORES, Division of Animal and Human Health Engineering, Department of Biosystems, Faculty of Bioscience Engineering, KU Leuven, 3001 Leuven, Belgium.
This study introduces a 3D-printed mini-bioreactor for rapid cell therapy bioprocess optimization. The system enables parallel cultures and AI-driven development, accelerating the path to clinical translation.
Area of Science:
- Biotechnology
- Cell Therapy
- Bioprocess Engineering
Background:
- Cell therapies show promise but face challenges in clinical translation due to lengthy development and suboptimal processing.
- Optimizing bioprocesses requires extensive, costly, and resource-intensive experimentation.
Purpose of the Study:
- To develop a modular, 3D-printed mini-bioreactor for parallelized stirred cell cultures.
- To enable AI-driven bioprocess development through real-time monitoring and data generation.
- To efficiently screen and optimize bioprocess parameters for cell therapy development.
Main Methods:
- A modular, 3D-printed scaled-down bioreactor system for parallel stirred cell cultures.
- Integration of real-time monitoring of critical culture parameters.
- Application of a sequential screening design to evaluate bioprocess parameters (e.g., inoculum, surface area ratio, rotation speed).
- Implementation of a soft-sensing framework using metabolic indicators to estimate cell number.
Main Results:
- The mini-bioreactor facilitated rapid, cost-effective, and efficient optimization of bioprocess conditions.
- The integrated sensor system enabled non-invasive estimation of cell number and culture dynamics.
- Cells expanded in the mini-bioreactor maintained stemness and multipotency, confirmed by successful differentiation into osteogenic, chondrogenic, and adipogenic lineages.
Conclusions:
- The developed mini-bioreactor system accelerates cell therapy bioprocess development and optimization.
- Real-time monitoring and soft-sensing provide valuable insights for efficient process control.
- The system supports the generation of high-quality cells for therapeutic applications.
More Related Videos
Related Concept Videos
Scale-Up Processes
Upstream Processing
Bioreactor Controls-III
Bioreactor Design and Operational System
Designing Growth Media for Bioreactors
Bioreactor Controls-II

